[artículo] 
inJournal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 2 (Abril) . - pp. 118-125

Título :	Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder
Tipo de documento:	texto impreso
Autores:	Jonathan R.T. Davidson, Autor ; Jose A. Yaryura-Tobias, Autor ; Robert L. DuPont, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 118-125
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antidepresivos, Ansiedad, Fluvoxamina, Disfunción Sexual - Fisiológica, Trastornos del comportamiento social.
Resumen:	Generalized social anxiety disorder is a highly prevalent anxiety disorder with deleterious effects on social and family relationships, as well as work performance. We report the results of a multicenter, randomized, placebo-controlled trial comparing the efficacy, safety, and tolerability of fluvoxamine controlled release (CR) to placebo in patients with generalized social anxiety disorder.
Link:	./index.php?lvl=notice_display&id=30959

[artículo] Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder [texto impreso] / Jonathan R.T. Davidson, Autor ; Jose A. Yaryura-Tobias, Autor ; Robert L. DuPont, Autor . - 2023 . - pp. 118-125.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 2 (Abril) . - pp. 118-125

Palabras clave:	Antidepresivos, Ansiedad, Fluvoxamina, Disfunción Sexual - Fisiológica, Trastornos del comportamiento social.
Resumen:	Generalized social anxiety disorder is a highly prevalent anxiety disorder with deleterious effects on social and family relationships, as well as work performance. We report the results of a multicenter, randomized, placebo-controlled trial comparing the efficacy, safety, and tolerability of fluvoxamine controlled release (CR) to placebo in patients with generalized social anxiety disorder.
Link:	./index.php?lvl=notice_display&id=30959